(Q34544658)

2 August 2017

1 reference

title

Anti-androgens for the treatment of hirsutism (English)

1 reference

2 August 2017

1 reference

1

Enrico Carmina

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

11

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

357-363

1 reference

A novel use of spironolactone: treatment of hirsutism

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Side-effects of spironolactone therapy in the hirsute woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Cyproterone acetate for severe hirsutism:results of a double-blind dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: Efficacy, metabolic and endocrine effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

The clinical development of a 5α-reductase inhibitor, finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

Do hyperandrogenic women with normal menses have polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.357

10.1517/13543784.11.3.357

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference